RAB14 levels correlated with lymph node metastasis, poor differentiation, a high-grade tumor stage, as well as unfavorable prognostic outcomes for BLCA patients in our previous study [20]. This evidence concerns the gene RAB14 and bladder transitional cell carcinoma.